Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial-Reference-Cited by-同舟云学术

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Published:2008-09 Issue:9644 Volume:372 Page:1163-1173
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Windecker Stephan,Serruys Patrick W,Wandel Simon,Buszman Pawel,Trznadel Stanislaw,Linke Axel,Lenk Karsten,Ischinger Thomas,Klauss Volker,Eberli Franz,Corti Roberto,Wijns William,Morice Marie-Claude,di Mario Carlo,Davies Simon,van Geuns Robert-Jan,Eerdmans Pedro,van Es Gerrit-Anne,Meier Bernhard,Jüni Peter

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization;Morice;N Engl J Med,2002

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

3. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

4. Coronary-artery stents;Serruys;N Engl J Med,2006

5. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents;Stone;N Engl J Med,2007

Cited by 547 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-stent Re-endothelialization Strategies: Cells, ECM, and Extracellular Vesicles;Tissue Engineering Part B: Reviews;2024-08-21

2. Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial;European Journal of Internal Medicine;2024-08

3. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

4. Prediction value of pericoronary fat attenuation index for coronary in-stent restenosis;European Radiology;2024-01-15

5. Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI;American Heart Journal;2023-11